ER Bcl-2在宫颈病变发生中的相关性研究

Correlation of ER with Bcl-2 in cervical cancer and pre-cancerous lesion

  • 摘要:
      目的  探讨ER、Bcl-2蛋白在不同程度宫颈病变中的相关性及意义。
      方法  免疫组织化学检测慢性宫颈炎20例、低度宫颈上皮内瘤变30例、高度宫颈上皮内瘤变70例及80例宫颈癌组织中ER和Bcl-2蛋白的表达。
      结果  ER在慢性宫颈炎组中阳性率为75%,随着宫颈病变程度的加重,其表达率逐渐降低(χ2=24.266,P < 0.01),与慢性宫颈炎组比较,CINⅡ~Ⅲ组和宫颈鳞癌组差异有统计学意义,CINⅠ组差异无统计学意义(χ2=0.751,P=0.386)。与肿瘤组织类型及病理分级无关;BCL-2在宫颈鳞癌组中阳性率为75.38%,随着宫颈病变程度的加重,其表达率逐渐增高(χ2=27.715,P < 0.01),与慢性宫颈炎组比较,CINⅠ组、CINⅡ~ Ⅲ组及宫颈鳞癌组差异均有统计学意义。与宫颈鳞癌病理分级相关(χ2=4.862,P=0.027),与肿瘤组织类型无关(P=0.500);CIN Ⅱ~Ⅲ组中联合表达阳性率为38.57%(27/70),宫颈鳞癌组中联合表达阳性率为15.38%(10/65),差异具有统计学意义(χ2=9.108,P=0.003)。CINⅡ~Ⅲ组中ER与Bcl-2蛋白表达存在相关(r=0.506,P < 0.01),其余组中无相关关系。
      结论  在宫颈病变的进展中,ER和Bcl-2表达呈相反趋势,在CINⅡ~Ⅲ组中有相关性,联合表达阳性可能是宫颈高度上皮内瘤变发生的主要机制之一。

     

    Abstract:
      Objective   This study aimed to investigate the relationship between estrogen receptor (ER) and Bcl-2 in cervical cancer and precancerous lesions.
      Methods   ER and Bcl-2 were evaluated by immunohistochemistry in 20 non-tumor tissues, 30 low-grade cervical intraepithelial neoplasias, 70 high-grade cervical intraepithelial neoplasias, and 80 cervical cancers.
      Results   The positive rate of ER was 75% in non-tumor tissues; this rate decreased with disease severity (χ2=24.266, P < 0.01). The overexpression of ER protein was remarkably lower in cervical intraepithelial neoplasias (CIN) Ⅱ-Ⅲ and carcinomas than in non-tumorous cervices. Differences were not significant between CINⅠ and non-tumorous cervices (χ2=0.751, P=0.386). Furthermore, ER expression was not correlated with histological type and tumor grade. The positive rate of Bcl-2 was 75.38% in squamous cell carcinoma. This rate increased with disease severity (χ2=27.715, P < 0.01). The Bcl-2 protein overexpression was remarkably higher in CINⅠ, CIN Ⅱ-Ⅲ, and carcinomas than in non-tumorous cervices. Bcl-2 expression was also not correlated with histological type (P=0.500); by comparison, Bcl-2 expression was correlated with tumor pathological grade (χ2=4.862, P=0.027). The co-expression of ER and Bcl-2 was 38.57% and 15.38% in CIN Ⅱ-Ⅲand squamous cell carcinoma, respectively; the differences between these two values were significant (χ2=9.108, P=0.003). A correlation between ER and Bcl-2 was observed in CIN Ⅱ-Ⅲ (r=0.506, P < 0.01); no correlation was observed between other groups.
      Conclusion   ER expression was inversely correlated with Bcl-2 in cervical cancer progression. The co-expression of these markers may have an important function in the course of high-grade cervical intraepithelial neoplasia.

     

/

返回文章
返回